Microsoft Corporation
$3.68T- Market cap
- $3.71T
- Debt
- +$49.52B
- Cash
- −$76.84B
Capital structure 99% equity / 1% debt · EV / Revenue 11.10x · EV / EBITDA 17.97x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: MSFT stock price vs MOH: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at MOH's multiple
Needs MOH P/E.
Implied fair value · at MSFT's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: MSFT FY 2026 (ended Jun 30, 2026) · MOH FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
11 fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 99% equity / 1% debt · EV / Revenue 11.10x · EV / EBITDA 17.97x
Capital structure 74% equity / 26% debt · EV / Revenue 0.13x · EV / EBITDA 6.90x
MSFT carries the larger enterprise value at $3.68T against $5.99B; MOH trades on the lower EV / Revenue multiple (0.13x vs 11.10x); MOH on the lower EV / EBITDA (6.90x vs 17.97x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
MICROSOFT CORPORATION · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
MOLINA HEALTHCARE, INC. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.11x
0.93x
Net debt / EBITDA
Leverage against operating earnings
-0.13x
-5.17x
Cash and equivalents
Liquid reserves on the balance sheet
$76.84B
$8.26B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Apple Inc.
MSFT vs AAPL
Alphabet Inc.
MSFT vs GOOGL
AMAZON COM INC
MSFT vs AMZN
ADOBE INC.
MSFT vs ADBE
NVIDIA CORP
MSFT vs NVDA
CISCO SYSTEMS, INC.
MSFT vs CSCO
UnitedHealth Group Incorporated
MSFT vs UNH
HUMANA INC
MSFT vs HUM
Cigna Group
MSFT vs CI
Elevance Health, Inc.
MSFT vs ELV
$49.52B
$3.77B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe MSFT can sustain its 14.9% revenue growth and 43.6% ROIC while maintaining its current premium margins, then hold or add selectively; otherwise, the model-implied -40.5% downside and DCF range argue for caution because the current price already embeds a large quality premium.
On a relative P/E basis, MSFT trades at 35.5x versus MOH at 20.1x, while the model’s implied price for MSFT is $274.54 versus the current $461.19, suggesting a -40.5% downside gap. The valuation picture is mixed because MSFT’s premium multiple is supported by much stronger margins and returns, but the comparison still flags the current price as rich relative to the input model.
Supporting Metrics